Sanggenone K is primarily studied for its biological activities, particularly in the field of pharmacology and medicinal chemistry. It exhibits strong anti-inflammatory effects by inhibiting key signaling pathways such as NF-κB, making it a potential candidate for developing treatments for chronic inflammatory diseases. Research also shows that Sanggenone K has anticancer properties, inducing apoptosis in various cancer cell lines including liver, breast, and colon cancers through the modulation of pro-apoptotic and anti-apoptotic proteins. Additionally, it demonstrates antioxidant activity, helping to reduce oxidative stress in cellular models. Due to its ability to cross the blood-brain barrier, it is being explored for neuroprotective applications, particularly in neurodegenerative conditions like Alzheimer’s disease. Its antimicrobial effects against certain pathogens further expand its therapeutic potential. Most studies remain in the preclinical stage, focusing on in vitro and animal models.